This Week in Nature

In this week's Nature, a team led by scientists from the National Cancer Institute reports on the discovery of genes that are required for certain cancer immunotherapies to be effective and which contribute to drug-resistant tumors. Using a genome-scale CRISPR/Cas9 screen, the team profiled genes whose loss in tumor cells impaired the effector function of CD8-positive T cells (EFT).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.